# Evaluation of the Gastrointestinal Manifestation of Fabry's Disease

> **NCT02798458** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 48 (actual)

## Conditions studied

- Fabry's Disease

## Interventions

- **DEVICE:** Smartpill
- **PROCEDURE:** Endoscopic Mucosal Resection

## Key facts

- **NCT ID:** NCT02798458
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2021-11-10
- **Final completion:** 2022-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02798458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02798458, "Evaluation of the Gastrointestinal Manifestation of Fabry's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02798458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*